INCY

insider transactions

INCYTE CORP — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-38.4K

0 buy · 38.4K sell

Net value · 90d

-$3.7M

$0 in · $3.7M out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 38.4K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 17, 26

Jacqualyn A Fouse

Director

$0

766 sh

Own New
Grant·A
Jun 17, 26

Jacqualyn A Fouse

Director

$0

454 sh

Own +41%
Grant·A
Jun 17, 26

Paul J Clancy

Director

$0

17.3K sh

Own New
Grant·A
Jun 10, 26

Otis W Brawley

Director

$0

9.2K sh

Own New
Grant·A
Jun 8, 26

Katherine A High

Director

$0

6.1K sh

Own New
Grant·A
Jun 8, 26

Katherine A High

Director

$0

1.6K sh

Own +12%
Grant·A
Jun 8, 26

Edmund Harrigan

Director

$0

6.1K sh

Own New
Grant·A
Jun 8, 26

Edmund Harrigan

Director

$0

1.6K sh

Own +8%
Grant·A
Jun 8, 26

Jacqualyn A Fouse

Director

$0

6.1K sh

Own New
Grant·A
Jun 8, 26

Jacqualyn A Fouse

Director

$0

1.6K sh

Own +8%
Grant·A
Jun 8, 26

Paul J Clancy

Director

$0

6.1K sh

Own New
Grant·A
Jun 8, 26

Paul J Clancy

Director

$0

1.6K sh

Own +7%
Grant·A
Jun 8, 26

Otis W Brawley

Director

$0

6.1K sh

Own New
Grant·A
Jun 8, 26

Otis W Brawley

Director

$0

1.6K sh

Own +15%
Exercise·M
Jun 4, 26

Thomas Tray

Principal Accounting Officer · 10b5-1

$0

2.6K sh

Own New
Sell·S
Jun 4, 26

Thomas Tray

Principal Accounting Officer · 10b5-1

$263.9K

2.6K sh · $100.00

Own -11%
Exercise·M
Jun 4, 26

Thomas Tray

Principal Accounting Officer · 10b5-1

$221.2K

2.6K sh · $83.83

Own +12%
Other·F
Jun 1, 26

Pablo J Cagnoni KEY

President, Global Head of R&D

$2.4M

25.5K sh · $95.59

Own -10%
Sell·S
May 26, 26

Thomas Tray

Principal Accounting Officer · 10b5-1

$199.7K

2.1K sh · $97.35

Own -9%
Exercise·M
May 19, 26

Paul J Clancy

Director · 10b5-1

$0

15.0K sh

Own New
Sell·S
May 19, 26

Paul J Clancy

Director · 10b5-1

$1.4M

15.0K sh · $94.93

Own -39%
Exercise·M
May 19, 26

Paul J Clancy

Director · 10b5-1

$1.3M

15.0K sh · $84.53

Own +63%
Grant·A
May 6, 26

Steven H Stein

CMO & Head of Late-Stage Dev.

$0

44.1K sh

Own +129%
Grant·A
May 6, 26

Pablo J Cagnoni KEY

President, Global Head of R&D

$0

31.5K sh

Own +13%
Grant·A
May 4, 26

Suketu Upadhyay KEY

EVP & Chief Financial Officer

$0

13.2K sh

Own +100%
Grant·A
May 4, 26

Suketu Upadhyay KEY

EVP & Chief Financial Officer

$0

38.4K sh

Own New
Grant·A
May 4, 26

Suketu Upadhyay KEY

EVP & Chief Financial Officer

$0

26.3K sh

Own New
Exercise·M
Apr 17, 26

Pablo J Cagnoni KEY

President, Global Head of R&D · 10b5-1

$0

12.6K sh

Own +83%
Exercise·M
Apr 17, 26

Pablo J Cagnoni KEY

President, Global Head of R&D · 10b5-1

$0

6.1K sh

Own +29%
Sell·S
Apr 17, 26

Pablo J Cagnoni KEY

President, Global Head of R&D · 10b5-1

$1.8M

18.7K sh · $96.50

Own -7%
Exercise·M
Apr 17, 26

Pablo J Cagnoni KEY

President, Global Head of R&D · 10b5-1

$905.6K

12.6K sh · $71.93

Own +5%
Exercise·M
Apr 17, 26

Pablo J Cagnoni KEY

President, Global Head of R&D · 10b5-1

$390.4K

6.1K sh · $64.25

Own +2%
Grant·A
Apr 15, 26

Steven H Stein

CMO & Head of Late-Stage Dev.

$0

39.0K sh

Own +114%
Exercise·M
Apr 15, 26

William Meury KEY

Chief Executive Officer

$0

125.0K sh

Own +346%
Grant·A
Apr 15, 26

Pablo J Cagnoni KEY

President, Global Head of R&D

$0

27.9K sh

Own +12%
Grant·A
Mar 31, 26

Edmund Harrigan

Director

$25.3K

269 sh · $94.12

Own +1%
Grant·A
Mar 31, 26

Paul J Clancy

Director

$24.9K

265 sh · $94.12

Own +1%
Other·F
Mar 25, 26

Matteo Trotta

EVP, GM, Dermatology US

$49.5K

537 sh · $92.23

Own -3%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 17, 2026	Jacqualyn A Fouse	Director	Grant A	766	New	—	$0
Jun 17, 2026	Jacqualyn A Fouse	Director	Grant A	454	+41%	—	$0
Jun 17, 2026	Paul J Clancy	Director	Grant A	17.3K	New	—	$0
Jun 10, 2026	Otis W Brawley	Director	Grant A	9.2K	New	—	$0
Jun 8, 2026	Katherine A High	Director	Grant A	6.1K	New	—	$0
Jun 8, 2026	Katherine A High	Director	Grant A	1.6K	+12%	—	$0
Jun 8, 2026	Edmund Harrigan	Director	Grant A	6.1K	New	—	$0
Jun 8, 2026	Edmund Harrigan	Director	Grant A	1.6K	+8%	—	$0
Jun 8, 2026	Jacqualyn A Fouse	Director	Grant A	6.1K	New	—	$0
Jun 8, 2026	Jacqualyn A Fouse	Director	Grant A	1.6K	+8%	—	$0
Jun 8, 2026	Paul J Clancy	Director	Grant A	6.1K	New	—	$0
Jun 8, 2026	Paul J Clancy	Director	Grant A	1.6K	+7%	—	$0
Jun 8, 2026	Otis W Brawley	Director	Grant A	6.1K	New	—	$0
Jun 8, 2026	Otis W Brawley	Director	Grant A	1.6K	+15%	—	$0
Jun 4, 2026	Thomas Tray 10b5-1	Principal Accounting Officer	Exercise M	2.6K	New	—	$0
Jun 4, 2026	Thomas Tray 10b5-1	Principal Accounting Officer	Sell S	2.6K	-11%	$100.00	$263.9K
Jun 4, 2026	Thomas Tray 10b5-1	Principal Accounting Officer	Exercise M	2.6K	+12%	$83.83	$221.2K
Jun 1, 2026	Pablo J Cagnoni KEY	President, Global Head of R&D	Other F	25.5K	-10%	$95.59	$2.4M
May 26, 2026	Thomas Tray 10b5-1	Principal Accounting Officer	Sell S	2.1K	-9%	$97.35	$199.7K
May 19, 2026	Paul J Clancy 10b5-1	Director	Exercise M	15.0K	New	—	$0
May 19, 2026	Paul J Clancy 10b5-1	Director	Sell S	15.0K	-39%	$94.93	$1.4M
May 19, 2026	Paul J Clancy 10b5-1	Director	Exercise M	15.0K	+63%	$84.53	$1.3M
May 6, 2026	Steven H Stein	CMO & Head of Late-Stage Dev.	Grant A	44.1K	+129%	—	$0
May 6, 2026	Pablo J Cagnoni KEY	President, Global Head of R&D	Grant A	31.5K	+13%	—	$0
May 4, 2026	Suketu Upadhyay KEY	EVP & Chief Financial Officer	Grant A	13.2K	+100%	—	$0
May 4, 2026	Suketu Upadhyay KEY	EVP & Chief Financial Officer	Grant A	38.4K	New	—	$0
May 4, 2026	Suketu Upadhyay KEY	EVP & Chief Financial Officer	Grant A	26.3K	New	—	$0
Apr 17, 2026	Pablo J Cagnoni KEY 10b5-1	President, Global Head of R&D	Exercise M	12.6K	+83%	—	$0
Apr 17, 2026	Pablo J Cagnoni KEY 10b5-1	President, Global Head of R&D	Exercise M	6.1K	+29%	—	$0
Apr 17, 2026	Pablo J Cagnoni KEY 10b5-1	President, Global Head of R&D	Sell S	18.7K	-7%	$96.50	$1.8M
Apr 17, 2026	Pablo J Cagnoni KEY 10b5-1	President, Global Head of R&D	Exercise M	12.6K	+5%	$71.93	$905.6K
Apr 17, 2026	Pablo J Cagnoni KEY 10b5-1	President, Global Head of R&D	Exercise M	6.1K	+2%	$64.25	$390.4K
Apr 15, 2026	Steven H Stein	CMO & Head of Late-Stage Dev.	Grant A	39.0K	+114%	—	$0
Apr 15, 2026	William Meury KEY	Chief Executive Officer	Exercise M	125.0K	+346%	—	$0
Apr 15, 2026	Pablo J Cagnoni KEY	President, Global Head of R&D	Grant A	27.9K	+12%	—	$0
Mar 31, 2026	Edmund Harrigan	Director	Grant A	269	+1%	$94.12	$25.3K
Mar 31, 2026	Paul J Clancy	Director	Grant A	265	+1%	$94.12	$24.9K
Mar 25, 2026	Matteo Trotta	EVP, GM, Dermatology US	Other F	537	-3%	$92.23	$49.5K

About INCY insider trading

This page tracks insider transactions for INCYTE CORP (INCY) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.